Explore All 3116 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | February 7, 2011 |
| Target | Accuri Cytometers |
| Sector | Life Science |
| Buyer(s) | Becton Dickinson |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1897 |
| Sector | Medical Products |
| Employees | 70,000 |
| Revenue | 20.2B USD (2024) |
Becton Dickinson is a global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. Becton Dickinson was incorporated in 1897 and is headquartered in Franklin Lake, New Jersey.
| Deal Context for Buyer | # |
|---|---|
| Overall | 8 of 30 |
| Sector: Life Science | 4 of 7 |
| Type: Add-on Acquisition | 8 of 25 |
| State: Michigan | 2 of 2 |
| Country: United States | 8 of 23 |
| Year: 2011 | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-10-04 |
Becton Dickinson and Co. - Critical Care & Extended Dwell Catheter Product
Franklin Lake, New Jersey, United States Becton, Dickinson and Co. - Critical Care & Extended Dwell Catheter Product consisting of blood pressure monitoring devices, and central venous, pulmonary artery and extended dwell catheters. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-07-27 |
Carmel Pharma AB
Molndal, Sweden Carmel Pharma ab engages in the manufacture and distribution of products that improve the quality of life of people who prepare, administer, and dispose of hazardous drugs. It offers the PhaSeal System, a closed-system drug transfer device that prevents hazardous drug interaction with the environment. |
Buy | - |